Moderna Starts Phase 1 Trial of Bundibugyo Ebola Vaccine
Moderna has begun the first human trial of its experimental vaccine targeting the Bundibugyo strain of Ebola, a virus for which no approved vaccine currently exists.
The Daily Verified Briefing
Recent verified news about Moderna, Inc. (MRNA), including story sentiment and market listing information.
Moderna has begun the first human trial of its experimental vaccine targeting the Bundibugyo strain of Ebola, a virus for which no approved vaccine currently exists.